|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.950 EUR | 0.00% |
|
-0.83% | -15.00% |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 04-27 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
Quotes 5-day view: Clinuvel Pharmaceuticals Limited
Delayed Quote Deutsche Boerse AG
| 2026-06-22 | 2026-06-23 | 2026-06-24 | 2026-06-25 | 2026-06-26 | |
|---|---|---|---|---|---|
| Last | €6.000 | €6.000 | €5.700 | €5.950 | €5.950 |
| Volume | 0 | 500 | 0 | 0 | 0 |
| Change | 0.00% | 0.00% | -5.00% | +4.39% | 0.00% |
| Opening | €6.000 | €5.900 | €5.700 | €5.950 | €5.950 |
| High | €6.000 | €6.000 | €5.700 | €5.950 | €5.950 |
| Low | €6.000 | €5.900 | €5.700 | €5.950 | €5.950 |
Performance
| 1 week | -0.83% | ||
| Current month | +12.26% | ||
| 1 month | +12.26% | ||
| 3 months | +3.30% | ||
| 6 months | -17.93% | ||
| Current year | -15.00% | ||
| 1 year | +5.50% | ||
| 3 years | -44.18% | ||
| 5 years | -67.26% | ||
| 10 years | +119.48% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
264
Daily volume ratio
0
Avg. Volume 20 sessions
1,570.8
Avg. Volume 20 sessions USD
1,787.95
Record volume 1
187,548
Record volume 2
154,534
Record volume 3
118,967
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
504,333,245
Market Cap (USD)
347,838,639
Net sales (AUD)
95,017,570
Net sales (USD)
65,533,618
Number of employees
16
Sales / Employee (AUD)
5,938,598
Sales / Employee (USD)
4,095,851
Free-Float
83.79 %
Free-Float capitalization (EUR)
420,670,983
Free-Float capitalization (USD)
290,136,777
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
5.92
Moving average 20 days
5.536
Moving average 50 days
5.523
Moving average 100 days
5.806
Price spread / (MMA5)
-0.50%
Price spread / (MMA20)
-6.96%
Price spread / (MMA50)
-7.18%
Price spread / (MMA100)
-2.42%
RSI 9 days
62.49
RSI 14 days
60.04
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.83% | +5.50% | -44.18% | 348M | |
| +2.06% | +3.76% | +21.48% | -19.31% | 64.39B | |
| +0.74% | +3.52% | +53.14% | +219.37% | 56.12B | |
| -3.10% | +34.30% | +34.30% | +34.30% | 40.54B | |
| -2.36% | -1.25% | -52.13% | -58.98% | 37.98B | |
| +6.97% | +9.89% | +70.21% | -23.28% | 31.89B | |
| +12.59% | +5.18% | +144.26% | -44.13% | 26.69B | |
| +5.78% | +15.81% | +60.64% | +80.73% | 22.73B | |
| -1.25% | -1.31% | -4.39% | +142.42% | 16.66B | |
| -0.81% | +5.91% | +67.70% | +124.13% | 16.6B | |
| Average | +2.06% | +4.32% | +40.07% | +41.11% | 31.39B | |
| Weighted average by Cap. | +1.96% | +4.11% | +39.17% | +46.35% |
Historical Quotes: Clinuvel Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 5.7 |  | 6 |
| 1 month | 5.1 | | 6 |
| Current year | 5.1 | | 7.39 |
| 1 year | 5.1 | | 7.68 |
| 3 years | 4.8 | | 12.68 |
| 5 years | 4.8 | | 27 |
| 10 years | 2.68 | | 27 |
Monthly variations
Annual variations
| 2026 | -15.00% | ||
| 2025 | -2.03% | ||
| 2024 | -28.00% | ||
| 2023 | -26.68% | ||
| 2022 | -26.04% | ||
| 2021 | +31.42% | ||
| 2020 | -22.21% | ||
| 2019 | +64.22% | ||
| 2018 | +102.08% | ||
| 2017 | +8.29% | ||
| 2016 | +176.72% | ||
| 2015 | -34.14% | ||
| 2014 | +327.03% | ||
| 2013 | -59.60% | ||
| 2012 | +33.90% | ||
| 2011 | -29.37% | ||
| 2010 | -75.48% | ||
| 2007 | +51.78% | ||
| 2006 | +103.62% | ||
| 2005 | -59.07% | ||
| 2004 | +3.85% |
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
- Quotes Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
